Clinical Trial Update: Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemotherapy plus cetuximab followed by surgical resection for locally advanced or recurrent thymoma or thymic carcinoma; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Carcinoma
• Thymoma

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Thymoma, Thymic Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING